In this plain language summary of publication from Neurodegenerative Disease Management, Dr Gavin Giovannoni and co-authors provide an overview of their article originally published in the journal Advances in Therapy. In this article, the researchers look at the results from the CLARITY and CLARITY Extension studies to determine what effect a 2-year course of treatment with cladribine tablets had on disability over 5 years in people with multiple sclerosis.
Read the full article here.
The original article on which this summary is based is called ‘Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension Studies’ and was originally published in the journal Advances in Therapy. The original article can be read here.